Intranasal Platelet-Rich Plasma With or Without Topical Insulin for Post-Inflammatory Anosmia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorAmin Javer
About this trial
This study evaluates whether adding topical insulin to intranasal platelet-rich plasma (PRP) improves smell recovery in adults with post-inflammatory anosmia. Participants will be randomly assigned to receive either intranasal PRP combined with topical insulin or intranasal PRP alone. Changes in olfactory function will be assessed over time to compare the effectiveness and safety of the two treatments.
Eligibility criteria
Qualifiers
Diagnosed with olfactory dysfunction despite olfactory training therapy
Loss of smell within the past 5 years
Loss of smell occurred after an infection
Platelet count is over 150,000 platelets per microliter
Disqualifiers
None
Trial design
Treatments tested in this trial
- Intranasal PRP Plus Topical Insulin
- Intranasal PRP Plus Saline (Placebo)
Treatment groups
20 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Amin Javer
Lead sponsor
St. Paul's Hospital, Canada
Sponsor institution
Source ClinicalTrials.gov